Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$276,344
+$132,885 QoQ
Shares Held
59,365
+137.5% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 141 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. LXEO ranks #227 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in LXEO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $276,344 59,365
2026-03-31 $143,459 24,993
2025-12-31 $702,408 70,736
2025-09-30 $127,899 19,262
2025-06-30 $61,606 15,325
2025-03-31 $39,589 11,409
2024-12-31 $73,406 11,156
2024-09-30 $67,275 7,442
2024-06-30 $53,589 3,341
2024-03-31 $52,825 3,369
2023-12-31 $966 72